Abstract

Program planning and evaluation is crucial to the Knight Cancer Institute's desire to continually improve and develop new strengths. This occurs at the Knight Cancer Institute through both external and internal review mechanisms. These can be grouped into two categories: external advisory board (EAB), and internal planning and review. The EAB provides a peer-review of research programs and shared resource facilities to evaluate producfivity and excellence. They also identify potential gaps in scientific expertise and suggest options for closing these gaps. The EAB evaluates the level of collaboration among basic scientists, translational/dinical scientists, and populations based investigators and makes recommendations of actions to enhance interactivity between these areas. Several regular forums have been initiated to support the growth and development of the Knight Cancer Institute, while ensuring collaborafion and partnership within a complex matrix organization. These include the Knight Senior Leadership Council, The Program Leaders Working Group, the Clinical Steering Committee, and the Shared Resource Advisory Committee. Programmatic retreats are also held to highlight individual program needs and inter-programmatic collaborations.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA069533-14
Application #
8340094
Study Section
Subcommittee G - Education (NCI)
Project Start
2011-07-20
Project End
2016-06-30
Budget Start
2011-07-20
Budget End
2012-06-30
Support Year
14
Fiscal Year
2011
Total Cost
$72,600
Indirect Cost

  Institution

Name
Oregon Health and Science University
Department
Type
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239

  Publications

Risom, Tyler; Langer, Ellen M; Chapman, Margaret P et al. (2018) Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer. Nat Commun 9:3815
Minnier, Jessica; Pennock, Nathan D; Guo, Qiuchen et al. (2018) RNA-Seq and Expression Arrays: Selection Guidelines for Genome-Wide Expression Profiling. Methods Mol Biol 1783:7-33
Su, Yulong; Pelz, Carl; Huang, Tao et al. (2018) Post-translational modification localizes MYC to the nuclear pore basket to regulate a subset of target genes involved in cellular responses to environmental signals. Genes Dev 32:1398-1419
Gast, Charles E; Silk, Alain D; Zarour, Luai et al. (2018) Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival. Sci Adv 4:eaat7828
Krey, Jocelyn F; Scheffer, Deborah I; Choi, Dongseok et al. (2018) Mass spectrometry quantitation of proteins from small pools of developing auditory and vestibular cells. Sci Data 5:180128
Rozanov, Dmitri V; Rozanov, Nikita D; Chiotti, Kami E et al. (2018) MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection. J Proteomics 176:13-23
Winters-Stone, Kerri M; Wood, Lisa J; Stoyles, Sydnee et al. (2018) The Effects of Resistance Exercise on Biomarkers of Breast Cancer Prognosis: A Pooled Analysis of Three Randomized Trials. Cancer Epidemiol Biomarkers Prev 27:146-153
Pennock, Nathan D; Martinson, Holly A; Guo, Qiuchen et al. (2018) Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer. J Immunother Cancer 6:98
Xu, Li; Gordon, Ryan; Farmer, Rebecca et al. (2018) Precision therapeutic targeting of human cancer cell motility. Nat Commun 9:2454
Chen, Emerson Y; Blanke, Charles D; Haller, Daniel G et al. (2018) A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer. Am J Clin Oncol 41:1193-1198

Showing the most recent 10 out of 277 publications